The introduction of nicotinamide as being a nicotine replacement in e-cigarette and smokeless merchandise signifies a significant regulatory problem to the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is known to act as a sedative at large dosages6. The claims produced by Nicotine River, ECBlend, together with other selle